Estrogen-dependent inherited angioedema

Transfusion and Apheresis Science

Volumn 29, Issue 3, 2003, Pages 215-219

  Binkley, Karen E ^a,c   Davis III, Alvin E ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTER FOR BLOOD RESEARCH   (United States)

^c NONE   (Canada)

Author keywords

Estrogen; Hereditary angioedema

Indexed keywords

ANDROGEN; COMPLEMENT COMPONENT C1S INHIBITOR; ESTROGEN; ESTROGEN DERIVATIVE; PROTEIN INHIBITOR; SEX HORMONE;

ANGIONEUROTIC EDEMA; AUTOSOMAL DOMINANT DISORDER; CONFERENCE PAPER; DISEASE TRANSMISSION; DRUG EFFECT; DRUG MECHANISM; GENE MUTATION; HUMAN; INHIBITION KINETICS; PATHOGENESIS; PROTEIN FUNCTION; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

EID: 0142231475     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2003.08.002     Document Type: Conference Paper

References (31)

1. Donaldson V.H., Rosen F.S. Hereditary angioneurotic edema: a clinical survey. Pediatrics. 37:1966;1017-1027.
2. Frank M.M., Gelfand J.A., Atkinson J.P. Hereditary angioedema: the clinical syndrome and its management. Ann. Int. Med. 84:1976;580-593.
3. Schapira M., Silver L.D., Scott C.F.et al. Prekallikrein activation and high-molecular weight kininogen consumption in hereditary angioedema. New Engl. J. Med. 308:1983;1050-1053.
4. Strang C.J., Cholin S., Spragg J.et al. Angioedema induced by a peptide derived from complement component C2. J. Exp. Med. 168:1988;1685-1688.
5. ′1- esterase. Am. J. Med. 35:1963;37-44.
6. Rosen F.S., Alper C.A., Pensky J., Klemperer M.R., Donaldson V.H. Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J. Clin. Invest. 50:1971;2143-2149.
7. Davis A.E. C1 inhibitor gene and hereditary angioedema. Volanakis J.E., Frank M.M. The human complement system in health and disease. 1998;455-480 Marcel Dekker, New York. [chapter 21]. Patients with hereditary angioneurotic edema J. Clin. Invest. 50:1971;2143.
8. Agostini A., Bergamaschini L., Martignoni G.C., Cicardi M., Marasini B. Treatment of acute attacks of hereditary angioedema with C1-inhibitor concentrate. Ann. Allergy. 44:1980;299-301.
9. Gadek J.E., Hosea S.W., Gelfand J.A.et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partially purified C1 inhibitor. New Engl. Med. 302:1980;542-546.
10. Waytes A.T., Rosen F.S., Frank M.M. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. New Engl. J. Med. 334:1996;1630-1634.
11. Shefler A.L., Austen K.F., Rosen F.S. Tranexamic acid therapy in hereditary angioneurotic edema. New Engl. J. Med. 287:1972;452-454.
12. Spaulding W.B. Methytestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann. Int. Med. 56:1960;739-745.
13. Gelfand J.A., Sherins R.J., Alling D.W., Frank M.M. Treatment of hereditary angioedema with danazol. New Engl. J. Med. 295:1976;1444-1484.
14. Falus A., Feher K., Walcz E.et al. Hormonal regulation of complement biosynthesis in human cell lines. I. Androgens and gamma-interferon stimulate biosynthesis and gene expression of C1 inhibitor in human cell lines U937 and HepG2. Mol. Immunol. 27:1990;191-195.
15. Alabdullah I.H., Sim R.B., Sheil J., Greally J.F. The effect of danazol on the production of C1inhibitor in the guinea pig. Complement. 1:1984;27-35.
16. Lappin D., McPhaden A., Yap P.et al. Monocyte C1-inhibitor synthesis in patients with C1-inhibitor deficiency. Eur. J. Clin. Invest. 19:1989;45-52.
17. Ogston D., Walker J., Campbell D.M. C1 inactivator in pregnancy. Thromb. Res. 23:1981;453-454.
18. Halbmayer W.M., Hopmeier P., Mannhalter C.et al. C1 esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia. Thromb. Haemostasis. 65(2):1991;134-138.
19. Cohen A.J., Laskin C., Tarlo S. C1 esterase inhibitor in pregnancy. J. Allergy Clin. Immunol. 90:1992;412-413.
20. Gordon E.M., Ratnoff O.D., Saito H., Donaldson V.H., Pensky J., Jones P.K. Rapid fibrinolysis, augmented Hageman factor (factor XII) titres and decreased C1 esterase inhibitor titres in women taking oral contraceptives. J. Lab. Clin. Med. 96:1980;762-769.
21. Gordon E.M., Williams S.R., Frencheck B., Mazur C.A., Speroff I. Dose dependent effects of postmenopausal oestrogen and progestin on antithrombin III and factor XII. J. Lab. Clin. Med. 111:1988;52-56.
22. Jespersen J., Kluft C. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen - levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII and C1 inactivator. Thromb. Haemostasis. 54:1985;454-459.
23. Farsetti A., Misiti S., Citarella F., Felici A., Andreoli M., Fantoni A.et al. Molecular basis of estrogen regulation of Hageman factor XII gene expression. Endocrinology. 136:1995;5076-5083.
24. Fossum S., Hoem N.O., Johannesen S., Korpberget M., Nylund E., Sandem S.et al. Contact factors in plasma from women on oral contraception - significance of factor XI for the measured activity of factor XII. Thromb. Res. 74:1994;477-478.
25. Madeddu P., Emanueli C., Song Q., Varoni M.V., Demontis M.P., Anania V. et al. Regulation of bradykinin B2-receptor expression by oestrogen. Br. J. Pharmacol. 121:1997;1763-1769.
26. Sumino H., Ichikawa S., Ohyama Y., Nakamura T., Kanda T., Sakamoto H.et al. Effects of hormone replacement therapy on serum angiotensin-converting enzyme activity and plasma bradykinin in postmenopausal women according to angiotensin-converting enzyme-genotype. Hypertens. Res. 26:2003;53-58.
27. Proudler A.J., Cooper A., Whitehead M., Stevenson J.C. Effects of oestrogen-only and oestrogen-progestogen replacement therapy upon circulating angiotensin I-converting enzyme activity in postmenopausal women. Clin. Endocrinol. 58:2003;30-35.
28. Binkley K.E., Davis A.E. III Clinical, biochemical and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J. Allergy Clin. Immunol. 106:2000;546-550.
29. Bork K., Barnstedt S.E., Koch P., Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet. 356:2000;213-217.
30. Binkley K.E., Davis A.E. Reply (Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission). J. Allergy Clin. Immunol. 107:2001;747-748.
31. Martin L., Degenne D., Toutain A.et al. Hereditary angioedema type III: an additional French pedigree with autosomal dominant transmission. J. Allergy Clin. Immunol. 107(4):2001;747-748.